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Abstract
Animal cells initiate cytokinesis in parallel with anaphase onset, when an actomyosin ring assembles and constricts through
localized activation of the small GTPase RhoA, giving rise to a cleavage furrow. Furrow formation relies on positional cues
provided by anaphase spindle microtubules (MTs), but how such cues are generated remains unclear. Using chemical
genetics to achieve both temporal and spatial control, we show that the self-organized delivery of Polo-like kinase 1 (Plk1)
to the midzone and its local phosphorylation of a MT-bound substrate are critical for generating this furrow-inducing signal.
When Plk1 was active but unable to target itself to this equatorial landmark, both cortical RhoA recruitment and furrow
induction failed to occur, thus recapitulating the effects of anaphase-specific Plk1 inhibition. Using tandem mass
spectrometry and phosphospecific antibodies, we found that Plk1 binds and directly phosphorylates the HsCYK-4 subunit of
centralspindlin (also known as MgcRacGAP) at the midzone. At serine 157, this modification creates a major docking site for
the tandem BRCT repeats of the Rho GTP exchange factor Ect2. Cells expressing only a nonphosphorylatable form of HsCYK-
4 failed to localize Ect2 at the midzone and were severely impaired in cleavage furrow formation, implying that HsCYK-4 is
Plk1’s rate-limiting target upstream of RhoA. Conversely, tethering an inhibitor-resistant allele of Plk1 to HsCYK-4 allowed
furrows to form despite global inhibition of all other Plk1 molecules in the cell. Our findings illuminate two key mechanisms
governing the initiation of cytokinesis in human cells and illustrate the power of chemical genetics to probe such regulation
both in time and space.
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Introduction
At the end of mitosis, a physical barrier must be established
between the segregated sister genomes to produce two distinct
cells. This process, termed cytokinesis, involves the assembly and
constriction of an actomyosin ring at the cell equator [1–3]. In
addition to its fundamental role in cell multiplication, cytokinesis
contributes to genome integrity, because cells that fail to complete
cytokinesis often reduplicate their chromosomes and centrosomes
in the following cell cycle. Such tetraploid cells are prone to further
genomic instability and display increased propensity for oncogenic
transformation in vitro and in vivo [4,5].
In metazoans, cytokinesis is intimately linked to the structure of
the anaphase spindle [6]. Both astral and spindle midzone
microtubules (MTs) provide cues that direct contractile ring
assembly to the equator, although the relative contribution of these
two MT populations has been hotly debated over the past 40 years
[7,8]. Recent evidence indicates that both mechanisms can be
active simultaneously and contribute redundantly to furrow
positioning [9–11].
In addition to positional cues provided by the anaphase spindle,
cytokinesis requires regulated changes in protein phosphorylation.
For example, declining Cdk1 activity at anaphase onset allows the
reversal of inhibitory phosphorylations on PRC1 and the MKLP1
subunit of centralspindlin, enabling these factors to bind and
bundle antiparallel MTs that constitute the spindle midzone
[12,13]. The other subunit of centralspindlin, known as HsCYK-4
or MgcRacGAP, contains a GTPase activator protein (GAP)
PLoS Biology | www.plosbiology.org 1 May 2009 | Volume 7 | Issue 5 | e1000111domain and directly interacts with the GTP exchange factor (GEF)
Ect2, and both HsCYK-4 and Ect2 are essential for equatorial
recruitment of the RhoA GTPase, the master regulator of
actomyosin dynamics during cytokinesis [14–19].
In contrast to Cdk1, other mitotic kinases, including Polo-like
kinase 1 (Plk1) and Aurora B, regulate cytokinesis positively [1–
3,20–22]. Because chronic Plk1 inactivation results in profound
mitotic defects that trigger the spindle checkpoint and cause a
terminal cell-cycle arrest in prometaphase, Plk1’s role during the
initiation of cytokinesis was not discovered until the recent advent
of fast-acting chemical inhibitors [23–27]. When applied to cells at
the metaphase-to-anaphase transition, these compounds rapidly
suppress Plk1 activity, cause mislocalization of Ect2, and block
RhoA-dependent initiation of contractile ring assembly [24,27–
29]. However, the substrates and biochemical mechanisms that
account for these inhibitor-induced phenotypes remain unknown.
A second and related issue concerns the spatial regulation of
Plk1 itself. While Plk1 predominantly resides at kinetochores and
centrosomes in prometaphase cells, it rapidly redistributes onto the
spindle midzone at anaphase onset [30]. This localization pattern
stems from Plk1’s synergistic phosphorylation of and docking with
multiple midzone components via its Polo-box domain (PBD),
which is a specialized phosphopeptide-binding module [31,32].
Accordingly, inhibiting Plk1 activity in anaphase cells disrupts this
positive-feedback mechanism and prevents Plk1’s targeting to the
midzone [24,27–29]. Nevertheless, the relationship between Plk1’s
spatial auto-regulation and the molecular events leading to RhoA
activation and contractile ring assembly remains unsettled,
because the PBD is also required for Plk1’s upstream functions
in prometaphase, without which cells are unable to satisfy the
spindle checkpoint [33,34]. Based on studies in which Plk1’s
midzone localization was indirectly perturbed through the
depletion of individual docking partners such as PRC1 [35–37]
or co-expression of dominant-negative Plk1 and spindle check-
point constructs [34], current models for cell division presume that
this self-organization is not required to recruit Ect2 to the midzone
or initiate contractile ring assembly [1,37–39]. However, this
interpretation is complicated by the fact that both dominant-
negative and RNAi assays are susceptible to incomplete pene-
trance and thus false-negative results, especially in signaling
pathways characterized by strong positive feedback and compe-
tition among multiple binding partners and substrates [40,41]. For
example, reducing Plk1 levels by 95% blocks chromosome bi-
orientation effectively but still leaves cells with enough Plk1 to
initiate furrowing if the spindle checkpoint is also down-regulated
[42], whereas furrowing does not occur if Plk1 activity is directly
and potently inhibited in anaphase using small molecules [24,27–
29].
To elucidate the spatial and molecular mechanisms by which
Plk1 triggers RhoA recruitment and contractile ring assembly, we
took advantage of a chemical genetic system for Plk1 inhibition
[24]. This system uses PLK1-null human retinal pigment epithelial
(RPE) cells complemented by a mutant Plk1 allele, whose catalytic
pocket has been enlarged to accept bulky purine analogs as ATP-
competitive inhibitors (Plk1
as, for analog-sensitive) [24]. Exposure
of Plk1
as cells to one such analog, 3-MB-PP1, abrogates all known
mitotic and cytokinetic functions of the kinase, albeit on a 100-fold
shorter time scale than gene deletion or RNAi. Importantly, 3-
MB-PP1 is inert when applied to cells expressing wild-type Plk1,
validating this compound as an allele-specific inhibitor in vivo
[22]. In this Research Article, we leverage this system to modulate
not only the timing of kinase signaling but also its geometry. We
demonstrate that, contrary to previous models, Plk1’s self-
organization at the midzone in fact plays a crucial role in
communicating the position of this equatorial landmark to the
RhoA network. We also show that one key step in this
communication involves the site-specific phosphorylation of the
RhoGAP subunit of the centralspindlin complex, HsCYK-4,
which creates a recognition site for a tandem BRCT repeat motif
located at the N terminus of Ect2. Together these findings provide
new insight into how Plk1 generates and amplifies the midzone-
derived signal for cell division.
Results
A Chemical Genetic System for Manipulating the
Geometry of Plk1 Activity in Anaphase Cells
As a first step, Plk1
as cells [24] were transduced with retroviruses
expressing either wild-type Plk1 (Plk1
wt) or a so-called ‘‘pincer’’
mutant (Plk1
AA) that can no longer bind phosphoserine or
phosphothreonine residues [32] (Figure 1A). Both proteins were




as/AA cells contained a kinase activity
that was resistant to 3-MB-PP1 but sensitive to BI 2536, a
pharmacologic inhibitor of Plk1 and related kinases [43]
(Figure 1B). However, Plk1
wt localized to the spindle midzone in
vivo, whereas Plk1
AA was diffusely distributed (Figure 1C). Next,
Plk1
as/wt and Plk1
as/AA cells were synchronized in prometaphase
with monastrol, released to allow bipolar spindle assembly, and
then briefly treated with 3-MB-PP1 to inhibit Plk1
as activity in
anaphase (Figure 1D). Plk1
wt fully complemented the cytokinesis
defects caused by Plk1
as inhibition, as judged by localization of
Ect2 at the spindle midzone, recruitment of RhoA to the
equatorial cortex, and furrow ingression (Figure 1D, middle row,
and Figure 1E). Plk1
as/wt cells were also completely resistant to 3-
MB-PP1 in long-term growth assays (Figure 1F). In sharp contrast,
Plk1
AA failed to rescue either cytokinesis onset (Figure 1D, bottom
row, and Figure 1E) or sensitivity to 3-MB-PP1 (Figure 1F). This
failure was not attributable to a cis-inhibitory effect of the PBD
itself, as comparable results were obtained when the entire PBD
was deleted (see below). These data suggest that, contrary to
previous models, the initiation of cytokinesis requires both the
Author Summary
During mitosis, the separation of duplicated chromosomes
and subsequent cytokinesis (cell division) are tightly
coupled processes. Cytokinesis must occur not only after
chromosomes have separated but also in the physical
space between the chromosomes, so that each daughter
cell inherits the appropriate genetic material. The mech-
anisms responsible for this cellular choreography are
poorly understood, however. We used chemical genetics
to dissect the role of a key regulator of cell division, Polo-
like kinase 1 (Plk1) in human cells. We show that, contrary
to previous models, the ability of Plk1 to seek out
microtubules that lie between the separated chromo-
somes (so-called midzone microtubules) provides the cell
with an affirmative command to divide. Once assembled at
this landmark, Plk1 phosphorylates HsCYK-4, a component
of the centralspindlin complex (so named because it
assembles at the spindle midzone) and enables binding
between HsCYK-4 and Ect2, another regulator of cell
division. Bound Ect2 then communicates with the machin-
ery that assembles the actin- and myosin-based contractile
ring, leading to division of the cell into two daughters. Our
work therefore reveals new insights into how Plk1
temporally and spatially orchestrates division of human
cells.
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PLoS Biology | www.plosbiology.org 2 May 2009 | Volume 7 | Issue 5 | e1000111Figure 1. Self-assembly of Plk1 at the spindle midzone is required to activate the Ect2-RhoA network and induce formation of
cleavage furrows. (A) Human PLK1
D/D cells were reconstituted with an EGFP-tagged analog-sensitive Plk1 allele (Plk1
as) and mCherry-tagged wild-
type (Plk1
wt) or pincer-defective (Plk1
AA) alleles that are analog-resistant. (B) Plk1 immunoprecipitates were incubated with [c-
32P]ATP and casein in
the presence of 3-MB-PP1 with or without BI 2536. (C) Plk1
AA cannot associate with the spindle midzone. Plk1
as/wt and Plk1
as/AA cells were stained
with EGFP- and mCherry-specific antibodies and processed for immunofluorescence as outlined in the Materials and Methods section. Scale bar,
10 mm. (D) A chemical genetic assay for cytokinesis initiation. Plk1
as, Plk1
as/wt, and Plk1
as/AA cells were synchronously released from a monastrol block
and treated with 3-MB-PP1 to acutely inhibit Plk1
as activity in early anaphase. Midzone localization of the Ect2/HsCYK-4 complex, cortical generation
of active RhoA, and furrow ingression were analyzed by immunofluorescence microscopy. Scale bar, 10 mm. (E) Quantification of cytokinesis onset.
Ect2 recruitment, cortical RhoA activation, and furrow ingression were determined by immunofluorescence microscopy (n=100 anaphase cells per
genotype). (F) Cells were cultured in the presence of various concentrations of 3-MB-PP1 for 8 d and stained with crystal violet to assess growth.
doi:10.1371/journal.pbio.1000111.g001
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PLoS Biology | www.plosbiology.org 3 May 2009 | Volume 7 | Issue 5 | e1000111catalytic activity of Plk1 and its self-regulated association with one
or more factors upstream of RhoA, most likely at the spindle
midzone.
The RhoGAP Subunit of Centralspindlin Is a Substrate
and Binding Partner of Plk1 at the Spindle Midzone
In surveying known RhoA regulators, we noted that the N
terminus of HsCYK-4 contains several potential Plk1 phosphor-
ylation sites (D/E/N-X-S/T-Q, where X represents any amino
acid and Q denotes a hydrophobic residue; MBY, unpublished
data, and Figure 2A) and is an excellent substrate for Plk1 in vitro
(Figure 2B). These findings were of interest, because we recently
isolated HsCYK-4 in an affinity-capture screen for PBD-binding
proteins [44] and observed modest but reproducible coprecipita-
tion of endogenous Plk1 and HsCYK-4 during late mitosis
(Figure 2C). Tandem mass spectrometry analysis of a purified
HsCYK-4 fragment (HsCYK-4N) phosphorylated by Plk1 in vitro
identified four major sites (S157, S170, S214, and S260; Figure S2)
that overlapped with in vivo phosphorylation sites (S157, S164,
S170, and S214) detected in global phosphoproteomics analyses
[45,46]. Mutating these residues to alanine (HsCYK-4N
5A)
strongly inhibited Plk1-mediated phosphorylation in vitro
(Figure 2B). To test whether phosphorylation of HsCYK-4
facilitates its recognition by the PBD, nonradioactive kinase
reactions were performed, resolved by SDS-PAGE, and subjected
to Far Western blotting using a GST-PBD fusion protein [44].
Whereas the Plk1-phosphorylated form of HsCYK-4 bound the
soluble PBD fragment, this interaction was suppressed upon
inhibition of Plk1 or mutation of all five phosphoacceptor sites
(Figure 2D).
To investigate the dynamics of HsCYK-4 phosphorylation in
vivo, we raised a phosphospecific antibody against serine 170
(pS170; Figure 3A and Figure S4). Whereas this site was minimally
modified in HCT116 cells that were synchronized in prometa-
phase with nocodazole, S170 phosphorylation increased dramat-
ically upon release from the nocodazole arrest, as cells progressed
through anaphase and cytokinesis (Figure 3B). Similar results were
obtained in HeLa cells, except that higher levels of pS170 were
detected during nocodazole arrest, presumably indicating a higher
steady-state ratio of kinase to phosphatase activity in this cell type
(Figure S3). Immunofluorescence microscopy with the pS170
antibody revealed strong phosphorylation of HsCYK-4 at the
spindle midzone (Figure 3C, top panels, and Figure S4). This
phosphorylation required both Plk1’s catalytic activity and a
functional PBD motif, as judged by the loss of the pS170 signal in
3-MB-PP1-treated Plk1
as and Plk1
as/AA cells, versus its mainte-
nance in identically treated Plk1
as/wt cells (Figure 3C, bottom
panels). Together, these results indicate that HsCYK-4 is a bona
fide substrate and docking partner of Plk1 at the spindle midzone.
HsCYK-4 Phosphorylation Controls Ect2 Localization and
Stimulates RhoA-Dependent Contractile Ring Assembly
To determine the physiologic role of HsCYK-4 phosphoryla-
tion, human RPE cells were transduced with retroviral constructs
expressing GFP-tagged and siRNA-resistant versions of HsCYK-
4
wt or HsCYK-4
5A. Both proteins localized to the spindle
midzone, indicating their incorporation into functional central-
spindlin complexes (Figure S4A). Each cell line (plus a control cell
line expressing GFP alone) was transfected with HsCYK-4 siRNA
and synchronized in late mitosis via timed release from a
monastrol block. Although Western blotting demonstrated a
profound bulk reduction in HsCYK-4 (Figure 4A), only about
50% of cells were depleted with sufficient penetrance to extinguish
the pS170 phosphoepitope (Figure 4B, second column). Through
careful analysis of cells co-stained for pS170 and RhoA network
components, we nevertheless obtained clear evidence that the
phosphorylated form of HsCYK-4 promotes the onset of
cytokinesis. As expected, control cells that were effectively depleted
of endogenous HsCYK-4 (and thus devoid of pS170) exhibited
severe defects in concentrating RhoA at the equatorial cortex,
targeting citron kinase (an established RhoA effector and myosin II
activator [16,47]) to the presumptive contractile ring, and furrow
ingression (Figure 4B, second row, and Figure 4C). Expression of
GFP-HsCYK-4
wt rescued the loss of pS170 and all other siRNA-
induced phenotypes (Figure 4B, third row). In contrast, GFP-
HsCYK-4
5A did not restore S170 phosphorylation, and these cells
continued to display pronounced defects in all aspects of
cytokinesis initiation (Figure 4B, bottom row, and Figure 4C).
Although it was not possible to costain cells for pS170 and Ect2,
both HsCYK-4-depleted and GFP-HsCYK-4
5A cells displayed
quantitatively similar defects in recruiting Ect2 to the midzone that
were proportionate to the loss of pS170 (Figure 4B and 4D). We
also observed a qualitatively similar difference in the frequency of
binucleated cells after siRNA transfection in asynchronous cultures
(14% versus 2% for GFP-HsCYK-4
wt; p=0.001 by Fisher’s exact
test). Thus, Plk1’s phosphorylation of HsCYK-4 plays a major role
in targeting Ect2 to the spindle midzone and in stimulating RhoA-
dependent contractile ring assembly at anaphase onset.
Phosphorylation of HsCYK-4 on Serine 157 Generates a
Primary Docking Site for the Tandem BRCT Repeats of
Ect2
The N terminus of Ect2 has complex regulatory functions: on
the one hand, this domain is required for Ect2’s binding to
HsCYK-4 [14,16] and is subject to inhibitory phosphorylation by
Cdk1 [14]. On the other hand, it also tightly interacts with Ect2’s
C-terminal GEF domain, resulting in intramolecular auto-
inhibition [48]. Structurally, this region contains two tandem
BRCA1 C-terminal (BRCT) repeats, a sequence motif that, in
some contexts, mediates phosphospecific protein–protein interac-
tions [49,50]. Thus, several distinct but nonexclusive models for
how Plk1 promotes assembly of the Ect2/HsCYK-4 complex have
been suggested [21,22,24,29]. One possibility is that Plk1
phosphorylates Ect2 to disrupt its intramolecular association,
thereby making the N-terminal domain more accessible to
HsCYK-4. Another possibility is that Plk1 directly generates a
phosphospecific Ect2-binding site within HsCYK-4. The mis-
localization of Ect2 in HsCYK-4
5A mutant cells (Figure 4B)
strongly supports the latter hypothesis. To test this explicitly, we
cotransfected HeLa cells with epitope-tagged versions of HsCYK-
4 (either wild-type or nonphosphorylatable) and an N-terminal
Ect2 fragment that is immune to both intramolecular and Cdk1-
dependent inhibition (myc-BRCT* [14]). Immunoprecipitation–
Western blotting studies confirmed reconstitution of the complex
and further showed that this interaction requires both Plk1 activity
in trans and one major Plk1 consensus site (S157) in cis (Figure 5A).
Similar results were also obtained using full-length Ect2 as the
binding partner (Figure S6). Motivated by these findings, we
generated a pS157-specific antibody and used it to confirm that
this residue is indeed phosphorylated in a Plk1-dependent manner
in vivo (Figure 5B and Figure S5). We conclude that Plk1
phosphorylation at S157 (an evolutionarily conserved residue in
HsCYK-4 orthologs; Figure 5C) generates the primary docking
site for Ect2, at least when assayed in solution. Nevertheless, other
Plk1 phosphorylation sites may act in parallel with S157 to
stabilize the Ect2/HsCYK-4 interaction at midzone MTs (JM and
PVJ, unpublished data; M. Glotzer, personal communication).
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PLoS Biology | www.plosbiology.org 4 May 2009 | Volume 7 | Issue 5 | e1000111Figure 2. The RhoGAP subunit of the centralspindlin complex, HsCYK-4, is a substrate and binding partner of Plk1 in vitro. (A) The N
terminus of HsCYK-4 contains multiple Plk1 phosphorylation sites. MS/MS spectra of Plk1-phosphorylated HsCYK-4 (1–288) are presented in Figure S2.
(B) HsCYK-4 is a Plk1 substrate in vitro. Recombinant HsCYK-4 fragments were used as substrates for Plk1 kinase assays. Where indicated, BTO-1 [25]
was added to inhibit Plk1 activity. (C) Plk1 associates with the Ect2/HsCYK-4 complex. HeLa cells were released from a nocodazole block and sampled
at the indicated timepoints. DSP-treated whole-cell extracts were immunoprecipitated with anti-HsCYK-4 or control goat IgG and immunoblotted for
Plk1 and Ect2. (D) Plk1 phosphorylation of HsCYK-4 promotes PBD docking. In vitro kinase reactions were performed as in (B), except that unlabeled
ATP was used. The reaction products were resolved by SDS-PAGE and subjected to Far Western blotting using a soluble GST-PBD fusion protein as
the probe. Comparable loading was verified by immunoblotting for HsCYK-4N via its chitin-binding domain (CBD) tag.
doi:10.1371/journal.pbio.1000111.g002
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of the Ect2-Centralspindlin Complex Generate the
Midzone-Based Signal for Cell Division
Together, our results suggest a simple model for how Plk1
generates the midzone-derived signal for furrow formation. At
anaphase onset, Plk1 is released from its early mitotic binding
partners through dephosphorylation of Cdk1-primed PBD-dock-
ing sites. Once liberated, the kinase self-organizes at the plus ends
of spindle MTs by binding to and phosphorylating multiple
midzone components, including the HsCYK-4 subunit of
centralspindlin. Once phosphorylated on serine 157, HsCYK-4
is able to recruit Ect2 to the midzone via the latter’s N-terminal
BRCT repeats, thereby concentrating the RhoGEF at the
midzone and perhaps also activating it conformationally [48].
The ultimate output of this midzone-localized signaling network is
an intense but narrow zone of cortical RhoA activity, and
consequently, an equatorial cleavage furrow [18].
This model not only explains why cytokinesis initiation is
disrupted when Plk1’s kinase activity is spatially dysregulated due
to mutation of the PBD (Figure 1), but also predicts that one
should be able to bypass this defect by targeting the kinase to the
midzone and allowing it to phosphorylate HsCYK-4 via a PBD-
independent mechanism. To test this prediction, we constructed
retroviruses that express either the catalytic domain of Plk1 alone
(Plk1
cat) or the same domain fused to the N terminus of HsCYK-4
(an allele we term Plk1
catC4) and introduced these constructs into
Plk1
as cells (Figure 6A and Figure S1). During anaphase, Plk1
cat
was found throughout the cell, while Plk1
catC4 accumulated
Figure 3. HsCYK-4 is an anaphase-specific Plk1 substrate at the midzone. (A) Validation of a pS170-specific antibody. Known amounts of
pS170 or S170 (unphosphorylated) peptides were spotted on PVDF and immunoblotted with anti-pS170 antibody to assess phosphoselectivity. (B)
Phosphorylation of S170 peaks during anaphase and telophase. HCT116 cells were synchronized by nocodazole block and release and either
immunoblotted directly (top panels) or subjected to immunoprecipitation of total HsCYK-4, followed by immunoblot detection of pS170. Note that
the securin destruction and mitotic exit data were recently reported [69] and are reproduced here to provide essential context. (C) Phosphorylation of
S170 occurs on the spindle midzone and requires both the catalytic activity and self-primed association of Plk1 with the spindle midzone. RPE cells of
the indicated genotypes were synchronized with monastrol, treated with 3-MB-PP1 in anaphase, and processed for immunofluorescence microscopy
to visualize Plk1
as, total HsCYK-4, and pS170. Scale bar, 10 mm.
doi:10.1371/journal.pbio.1000111.g003
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PLoS Biology | www.plosbiology.org 6 May 2009 | Volume 7 | Issue 5 | e1000111Figure 4. Plk1 phosphorylation of HsCYK-4 localizes Ect2 at the midzone and stimulates RhoA-dependent contractile ring assembly
at the equatorial cortex. (A) Human RPE cells were stably transduced with GFP-tagged siRNA-resistant HsCYK-4 alleles, or with the empty GFP
vector as a negative control, then transfected with HsCYK-4 siRNA. Samples were analyzed by SDS-PAGE and Western blotting 48 h after transfection.
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as/cat cells were
challenged with 3-MB-PP1, S170 phosphorylation, Ect2 recruit-
ment, equatorial RhoA activation, and furrow induction were all
strongly inhibited (Figure 6C, second row, and Figure 6D). In
contrast, a significant fraction of Plk1
as/catC4 cells executed all
three aspects of cytokinesis initiation and formed deep cleavage
furrows (Figure 6C, bottom rows). This functional rescue was
particularly striking given that the Plk1
catC4 fusion was expressed
at substantially lower levels than the untethered kinase domain
(Figure S1). Importantly, the complementing activity of the
Plk1
catC4 allele was limited to cytokinesis onset, as other essential
functions of Plk1 were not restored (Figure 6E).
To confirm and extend these results, we quantitatively analyzed
cleavage furrow dynamics by time-lapse videomicroscopy (Figure 7
and Figure S6). Plk1
as/cat cells treated with 3-MB-PP1 either
lacked furrows altogether (n=21 cells; Figure 7A) or formed weak
transient furrows that quickly collapsed (n=7). In contrast, 66% of
3-MB-PP1-treated Plk1
as/catC4 cells (n=12 of 18 cells; Figure 7A)
formed deep equatorial furrows, confirming rescue of cytokinesis
onset. However, unlike wild-type furrows (Plk1
as/wt cells; n=21,
Figure 7B), these reconstituted furrows were unable to progress
through abscission and ultimately regressed by the end of
telophase, producing binucleate cells (Figure 7C). These results
demonstrate chemical genetic separation of Plk1’s roles during the
early and late stages of cytokinesis and are consistent with recent
data showing that Plk1 binds and phosphorylates other midzone-
and midbody-specific proteins that are required to complete (but
not initiate) cell division [35,36,44,51,52].
Discussion
Cytokinesis must be temporally and spatially coordinated with
chromosome segregation in order to avoid genome polyploidiza-
tion, centrosome amplification, and chromosome breakage [4,53].
In stem cell niches, the plane of division must also be correctly
oriented relative to other asymmetrically distributed determinants
of cell fate [54]. Conversely, defects in cytokinesis increase the
likelihood of carcinogenesis [5], vividly highlighting the need to
develop a detailed understanding of this process. While individual
components of the cytokinetic apparatus are increasingly well
annotated, our knowledge of how these components interact with
one another at the systems level remains fragmentary [2]. In this
study, we show that the self-regulated recruitment of Plk1 to the
spindle midzone and its phosphorylation of the HsCYK-4 subunit
of centralspindlin encode positive cues for cleavage furrow
formation, thus providing new mechanistic insight into how
mammalian cell division is regulated.
First, by manipulating Plk1 geometry in anaphase cells, we
define a clear requirement for Plk1 activity at the midzone prior to
recruitment of Ect2, cortical up-regulation of the RhoA GTPase,
and contractile ring assembly. Although Plk1’s PBD-dependent
localization to the spindle midzone has long been appreciated
[30,34,55], conducting a direct test of whether (and how) this
spatial regulation contributes to the initial events in cell division
has been virtually impossible, as cells expressing only PBD-
deficient alleles of Plk1 are incapable of satisfying the spindle
checkpoint and entering anaphase [33]. As an indirect alternative,
RNAi-mediated depletion of individual Plk1 docking partners such
as PRC1 [12,36,37] was used to block Plk1 enrichment at the
midzone. Because such cells continue to form furrows, it was
concluded that the midzone-associated pool of Plk1 plays no
significant role upstream of the Ect2-RhoA network and
contractile ring assembly [1,37–39]. Based on the results obtained
here, we suggest instead that such depletions did not abolish the
full spectrum of PBD-dependent positive-feedback loops at the
spindle midzone. In support of this view, Plk1 eventually
accumulates on subcortical interzonal MTs in PRC1-depleted
cells [36], presumably via redundant interactions with other MT-
binding proteins such as MKLP2 [56] and HsCYK-4 (Figure 2). It
is also possible that the lack of a bona fide spindle midzone in
PRC1-depleted cells actually enhances furrowing by increasing the
number of interzonal MTs that contact the equatorial cortex [57].
In contrast, by using chemical genetics to inactivate or bypass all
PBD-dependent positive-feedback loops in anaphase cells, we are
now able to show that Plk1 self-organization at the midzone is
essential for cytokinesis onset in human cells. This regulatory
mechanism is conceptually similar to other positive-feedback loops
that govern Cdk1 activation at the G1/S and G2/M transitions
[58,59] and cyclin B and securin proteolysis at anaphase onset
[60,61]. However, it is unique in that it works by concentrating
Plk1 near its midzone-specific substrates, rather than by up-
regulating Plk1’s activity throughout the cytoplasm. Nevertheless,
like other positive-feedback loops, Plk1 self-organization makes
cytokinesis more switchlike—that is, more rapid and synchronous
relative to other late mitotic events—than would otherwise be the
case. Indeed, in cells expressing the active but unanchored kinase
fragment (Plk1
cat), furrows were not only rarer but also shallower
and more temporally heterogeneous than those induced by
midzone-localized versions of Plk1 (Figure 7 and Figure S6). We
suggest that Plk1-mediated cytokinesis synchrony could play an
important role in ensuring that cells initiate and complete division
before their license to do so expires, typically around 30 to 60 min
after anaphase onset [62–64].
Like Plk1, Aurora B also relocalizes onto the spindle midzone at
anaphase onset, resulting in an axial phosphorylation gradient that
can be detected using a fluorescence resonant energy transfer
(FRET)-based biosensor [65]. Although a Plk1-generated gradient
has yet to be detected by this method, our results show that Plk1’s
association with the midzone predicts whether or not an equatorial
cleavage furrow will form (Figures 6 and 7). If an anaphase Plk1
gradient does exist, its detection may require the development of
newer biosensors that can engage in PBD-mediated positive
feedback and thus mimic the behavior of Plk1’s anaphase-specific
substrates.
We have also demonstrated that HsCYK-4 is an in vivo
substrate of Plk1 at the spindle midzone, and that this
phosphorylation allows HsCYK-4 to be recognized by the tandem
BRCT repeats at the N terminus of Ect2. These results explain
We observed increased levels of both GFP-tagged polypeptides after depletion of endogenous HsCYK-4, possibly due to reduced competition for
MKLP1 or other stabilizing factors. Tubulin was used to confirm equal loading. (B) Cells were transfected as above, synchronized with monastrol, and
fixed 60 min after release from the monastrol block. The fraction of anaphase/telophase cells with pS170 staining at the midzone is indicated (green
numbers, second column) and was used to establish the efficiency of RNAi depletion and/or transgenic rescue in individual cells. The percentage of
pS170-positive and -negative cells with equatorially localized proteins or ingressing furrows was quantified for each genotype. Scale bar, 10 mm. (C
and D) Abrogation of HsCYK-4 phosphorylation prevents Ect2 recruitment to the spindle midzone and inhibits RhoA activation and contractile ring
assembly. The percentage of anaphase/telophase cells with accumulation of Ect2 at the midzone, incorporation of active RhoA or Citron-kinase into
the presumptive contractile ring, and furrow ingression was determined from four replicates in two separate experiments (n=100 cells/sample); error
bars denote SEM.
doi:10.1371/journal.pbio.1000111.g004
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PLoS Biology | www.plosbiology.org 8 May 2009 | Volume 7 | Issue 5 | e1000111Figure 5. Phosphorylation of HsCYK-4 on S157 creates a docking site for the BRCT repeats on Ect2. (A) HeLa cells were cotransfected
with plasmids expressing wild-type or non-phosphorylatable versions of FLAG-HsCYK-4 and a myc-tagged N-terminal fragment of Ect2 containing
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[24,27–29], and together with the contractile ring assembly defect
in cells expressing non-phosphorylatable HsCYK-4 (Figure 4),
they suggest that HsCYK-4 is Plk1’s major rate-limiting substrate
upstream of RhoA. Curiously, this pronounced phenotype
contrasts with the behavior of cells expressing dominant-negative
Ect2 fragments, as the latter activate RhoA and ingress their
furrows normally [16]. By their very nature, dominant-negative
experiments are difficult to judge for penetrance and specificity, as
it can always be argued that the endogenous protein’s function has
been inadequately antagonized, or that another factor (in this case,
a hypothetical negative regulator of furrowing) was also titrated.
However, a more interesting notion is that HsCYK-4 mutations
prevent not only Ect2 recruitment to the midzone but also relief of
its auto-inhibition (Figure 8) [48], whereas dominant-negative Ect2
fragments allow the RhoGEF to cycle on and off HsCYK-4 in an
activated state. Further experiments will be required to test this
idea and clarify whether additional modes of Ect2 regulation
operate in parallel with the mechanisms described here.
In summary, our findings indicate that Plk1 generates the
midzone-encoded stimulus for cell division by priming two
structurally distinct phosphopeptide-binding modules within Ect2
and Plk1 itself, thereby ensuring the robustness and fidelity of this
process (Figure 8). Curiously, although the proximal and distal
elements of this cytokinesis network (Plk1 and RhoA) are
universally conserved [66,67], the intermediate components that
both BRCT repeats but lacking an inhibitory Cdk1 phosphorylation site (1-352 T342A [14]; denoted here as myc-BRCT*). Mitotic cell extracts were
immunoprecipitated with anti-myc antibodies, then analyzed by SDS-PAGE and Western blotting with anti-FLAG and anti-myc antibodies to assess
binding. 3A denotes the S157A/S164A/S170A triple mutant; 2A indicates the S214A/T260A double mutant. To ensure specificity, control
immunoprecipitations were performed in the presence of myc peptide as a competitor. (B) Plk1 phosphorylates S157 in vivo. A pS157-specific
antibody was generated (see Materials and Methods and Figure S5) and used to stain 3-MB-PP1-treated Plk1
wt and Plk1
as cells. (C) Alignment of
amino acid sequences surrounding S157 in HsCYK-4 orthologs. Note that a Plk1 phosphorylation consensus site (D/E-x-S/T-Q) is conserved from
Drosophila to humans.
doi:10.1371/journal.pbio.1000111.g005
Figure 6. Recruiting Plk1 to the midzone via a PBD-independent mechanism reactivates the Ect2-RhoA network and induces
equatorial cleavage furrows. (A) Plk1
as cells were transduced with retroviruses expressing either the catalytic domain of Plk1 alone (Plk1
cat) or the
same domain fused to HsCYK-4 (Plk1
catC4) as FLAG-tagged proteins. (B) Plk1
catC4 is recruited to the midzone during anaphase. Immunofluorescence
microscopy was performed as in Figure 1B, except that anti-FLAG antibodies were used. Scale bar, 10 mm. (C) Plk1
catC4 can activate the Ect2-RhoA
network. Cells of each genotype were synchronized with monastrol, released, and treated with 3-MB-PP1 for 20 min. Phosphorylation of pS170, Ect2
recruitment, cortical RhoA recruitment, and incorporation of Citron kinase into the contractile ring were assessed by immunofluorescence
microscopy. Scale bar, 10 mm. (D) The percentage of cells with equatorially localized proteins or ingressing furrows was quantified for each genotype.
(E) Plk1
catC4 confers cytokinesis-specific rescue of Polo kinase function. Cells were cultured in the presence of 3-MB-PP1 for 8 d and stained with
crystal violet to assess growth.
doi:10.1371/journal.pbio.1000111.g006
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synchronized cells were released for 60 min into drug-free medium, followed by addition of 3-MB-PP1 and initiation of timelapse imaging (time 00).
Examples of cells that traversed anaphase (A) and either formed equatorial furrows (F) or failed to do so (X) are indicated (see also Videos S1 and S2).
Scale bar, 10 mm. (B) Biphasic furrow dynamics in Plk1
as/catC4 cells. At least 18 cells of each genotype were imaged as above, and the average depth of
the furrow relative to the initial equatorial diameter at anaphase onset was calculated. Furrow trajectories in individual cells are provided in Figure S6.
(C) Cytokinesis ultimately fails in Plk1
as/catC4 cells. Cells were synchronized in prometaphase by monastrol block and release as above. Thirty minutes
after monastrol release, 3-MB-PP1 was added to 10 mM for an additional 90 min to inhibit Plk1
as activity during mitotic exit. Adherent cells were
collected by trypsinization, fixed and stained with Hoechst 33352, and analyzed microscopically to determine the fraction of binucleated cells in each
population (n=3 determinations, 100 cells/sample; values are reported as means 6 SEM). Scale bar, 10 mm.
doi:10.1371/journal.pbio.1000111.g007
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missing or lack cognate phosphopeptide-binding domains in
unicellular organisms such as budding and fission yeast, which
establish their division sites without reference to spindle geometry
[68]. It is tempting to speculate that the MT dependence of
cytokinesis in metazoans is specifically related to the evolutionary
history of these regulators of cell division.
Finally, we note that although genetic and pharmacologic probes
are increasingly available for many cell cycle regulators, including
Plk1, these tools typically involve substantial tradeoffs between
temporal and spatial resolution. For instance, RNAi-based knock-
down/addback methods allow researchers to deplete or relocalize a
given enzyme, but require days to take effect. Conversely,
pharmacologic agents have much faster kinetics of onset, but their
high diffusibility limits their usefulness in selectively activating or
inhibiting an enzyme at a defined subcellular location. Furthermore,
distinguishing between the on-target and off-target effects of such
compounds can be quite difficult. As illustrated here, chemical
genetics can overcome these limitations and provide novel insights
that are inaccessible via other routes. Given existing methods for
gene replacement, similar systems can now be envisioned for most or
all of the 600 kinases in the mouse and human genomes, providing
powerful tools for both fundamental physiologic studies and
preclinical evaluation of these enzymes as therapeutic targets.
Figure 8. A model for Plk1-mediated generation of the midzone-derived signal for cell division. In prometaphase, high Cdk1 levels
maintain Ect2, centralspindlin, and PRC1 in a functionally inactive state. Upon Cdk1 inactivation at anaphase onset, the MKLP1 subunit of
centralspindlin and PRC1 are dephosphorylated and thus able to bind and bundle antiparallel MT arrays to form the spindle midzone [12,13]. At the
same time, Plk1 is released from its early mitotic substrates by dephosphorylation of Cdk1-primed PBD docking sites, and inhibitory phosphorylation
of Ect2 at Cdk1 sites is also reversed [14]. Plk1 then rapidly self-organizes onto the midzone via PBD- and activity-dependent positive-feedback loops
involving multiple substrates, including PRC1 [36], MKLP2 [56], and HsCYK-4 (this study). Furthermore, in the case of HsCYK-4, Plk1 phosphorylationa t
S157 also creates a docking site for the tandem BRCT repeats of Ect2, thereby targeting the RhoGEF to the midzone and perhaps stimulating its
activity [48]. The resulting increase in RhoA-GTP at the adjacent equatorial cortex promotes focal recruitment and activation of RhoA effectors needed
for actin polymerization and myosin II motor activity within the contractile ring [2,3].
doi:10.1371/journal.pbio.1000111.g008
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Cell Culture Procedures
All lines were propagated in the following media supplement-
ed with 10% fetal bovine serum and 100 units/ml penicillin-
streptomycin: HeLa and Phoenix retroviral packaging lines,
Dulbecco’s modified Eagle’s medium (DMEM); HCT116
colorectal carcinoma cells, McCoy’s 5A medium; and hTERT-
RPE1 retinal pigment epithelial cells, 1:1 mixture of DMEM and
Ham’s F-12 medium supplemented with 2.5 mM L-glutamine.
Plasmid transfections were performed on cells at 50–70%
confluence using Fugene 6 (Roche) and 8 mgt o t a lD N Ap e r
10
7 cells. For growth assays, cells were split 1:40 into 12-well
plates, and after 24 h, the indicated concentration of 3-MB-PP1
was added to the medium. When untreated control wells reached
confluence (typically day 8), the medium was aspirated, and
adherent cells visualized by fixation and staining with crystal
violet in buffered formalin. The generation of Plk1
as cells was
previously described [24]. To enable G418 selection, the FRT-
neo
R-FRT cassette used to disrupt the endogenous PLK1 locus in
these cells was excised via transient transfection with a FLP
recombinase plasmid. G418-sensitive clones obtained in this
manner were in all other respects indistinguishable from the
original Plk1
as cells.
Molecular Biology and Retroviral Transgenesis
Plasmid mutagenesis was performed using the QuikChange
XL II kit (Stratagene), and all inserts were fully sequenced to
verify their integrity. For stable retroviral transduction, inserts
were cloned into pQCXIN or pQCXIX (Clontech), and the
resulting constructs cotransfected with a VSV-G envelope
plasmid into Phoenix cells. Fresh medium was applied 24 h
post-transfection and harvested 24 h later, clarified by centrifu-
gation and filtration through a 0.4 mm membrane to remove cell
debris, and diluted 1:1 with complete medium containing 20 mg/
ml polybrene. Target cells were infected at 40–60% confluence
for 24–48 h, then selected with 0.4 mg/ml G418 for 7–10 d, or
alternatively expanded for FACS purification based on GFP or
mCherry positivity. In some cases, these polyclonal transductants
were further purified by limiting dilution to obtain individual
clones.
Protein Expression and Purification
Human Plk1 was expressed as a hexahistidine-tagged polypep-
tide in Sf9 cells using the FastBAC system (Invitrogen), purified by
nickel affinity chromatography, and dialyzed into storage buffer
containing 50 mM Tris, pH 8.0, 150 mM NaCl, and 10%
glycerol. Recombinant HsCYK-4N fragments were expressed as
chitin-binding domain (CBD) and hexahistidine fusions in the
Rosetta (DE3) Escherichia coli strain (Novagen) and purified by
nickel affinity chromatography.
Kinase Reactions and Chemicals
Kinase reactions were performed as previously described [24].
For radiolabeling experiments, [c-
32P]ATP was diluted with
100 mM cold ATP and incubated for 30 min at 30uC. For
nonradioactive reactions, 1 mM cold ATP was used. Chemicals
used in this study include 3-MB-PP1 (10 mM or as indicated), BI
2536 (200 nM), BTO-1 (Sigma, 50 mM), dithiobis[succinimidyl-
propionate] (DSP, Pierce, 1 mg/ml), monastrol (Calbiochem,
100 mM), nocodazole (Sigma, 0.2 mg/ml), RO-3306 (Calbio-
chem, 10 mM), S-trityl-L-cysteine (Acros Organics, 5 mM), and
thymidine (Calbiochem, 2.5 mM).
Mass Spectrometry
The in vitro kinase reaction of Plk1 and HsCYK-4N was boiled
in reducing sample buffer containing b-mercaptoethanol, separat-
ed by SDS-PAGE, and visualized by SYPRO Ruby staining (Bio-
Rad). The HsCYK-4 band was excised from the gel and cut in half
vertically. One-half was digested overnight at 37uC with an excess
of sequencing grade trypsin, the other with Glu-C, in order to
generate peptides with maximal coverage. Peptides were extracted
from the gel slices with 50% acetonitrile/0.1% formic acid and
concentrated in a Speed-Vac. The quenched tryptic and Glu-C
digests were mixed together and analyzed with an automated nano
LC/MS/MS system, using a 1200 series autosampler and nano
pump (Agilent Technologies) coupled to an LTQ XL ion trap
mass spectrometer (Thermo Electron). Peptides were eluted from a
75 mm 6 10 cm PicoFrit (New Objective) column packed with
5 mm Magic C-18AQ reversed phase beads (Michrom Biore-
sources) using a 70-min acetonitrile/0.1% formic acid gradient at
a flow rate of 250 nl/min to yield ,25-s peak widths. Data-
dependent LC/MS/MS spectra were acquired in 3-s cycles; each
cycle was of the following form: one full MS scan followed by eight
MS/MS scans in the ion trap on the most abundant precursor ions
subject to dynamic exclusion. Sites of phosphorylation were
established by searching the MS/MS spectra with the Spectrum
Mill software package (Agilent Technologies) using a database
containing the HsCYK-4 sequence and allowing variable
modification of Ser and Thr by phosphorylation. Labeled MS/
MS spectra that demonstrate phosphorylation at Ser157, Ser170,
Ser214, and Thr 260 are provided in Figure S2.
RNA Interference
For RNAi experiments, six silent mutations were introduced
into the target site (nt 1,294–1,312) of a validated HsCYK-4
siRNA duplex [14]. This siRNA-resistant open reading frame was
then cloned downstream of EGFP in pQCXIN and used to stably
transduce hTERT-RPE1 cells. To deplete endogenous HsCYK-4,
cells were plated into 6-well dishes and transfected with 150 pmol
siRNA and 5 ml Lipofectamine 2000 (Invitrogen). Twenty-four
hours later, cells were trypsinized, resuspended in 5 ml antibiotic-
free medium, and replated as follows: (i) one–twenty-fifth was
plated into 4-well chamber slides (Labtek), synchronized with
monastrol from 40–48 h post-transfection, released into monas-
trol-free medium for 50 min, and then fixed and processed for
immunofluorescence microscopy; (ii) one-tenth was replated into a
new 6-well dish, then collected 24 h later for determination of the
fraction of mononucleated versus binucleated cells by Hoechst
staining and microscopy; (iii) the remainder was passaged to a T-
25 flask and collected 24 h later for SDS-PAGE and immuno-
blotting.
Immunofluorescence and Live-Cell Microscopy
Cells were plated in 4-well chamber slides and grown to ,70%
density, synchronized in prometaphase with an 8-h treatment with
monastrol, then washed and released into monastrol-free medium.
Using time-lapse videomicroscopy, we determined that the initial
wave of anaphase cells can be detected approximately 50 min after
monastrol washout. Thus, where indicated 3-MB-PP1 was added
30 min after washout and maintained for a 20-min interval prior
to fixation with either 10% ice-cold trichloroacetic acid for 10 min
(to detect activated RhoA), 4% paraformaldehyde for 15 min
(Citron-kinase), or 100% ice-cold methanol for 15 min to
overnight (all other antigens). Fixed cells were washed once in
phosphate-buffered saline (PBS) and blocked for 30 min in 3%
bovine serum albumin (BSA) and 0.1% Triton X-100 in PBS
(PBSTx+BSA). Primary antibodies were applied in the same buffer
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Alexa 488-, 594-, or 647-conjugated goat secondary antibodies
were then applied in a similar manner, followed by DAPI
counterstaining and mounting in Prolong Plus antifade medium
(Invitrogen). To detect the goat anti-HsCYK-4 antibody, an
Alexa-coupled donkey anti-goat antibody was used as the
secondary antibody, prior to incubation with goat-derived
secondary antibodies. Antibody dropout experiments were includ-
ed to verify specificity of staining and lack of crosstalk. Equatorial
enrichment of antigens was ascertained by qualitative classification
of cells in a blinded manner. Image acquisition was performed on
a Nikon TE2000 inverted microscope equipped with 106 and
406 long working distance and 1006 oil objectives, single-
bandpass excitation and emission filters, Hamamatsu ORCA ER
camera, a temperature-controlled stage enclosure with CO2
support (Solent Scientific), and MetaMorph software (Molecular
Devices). Panels were cropped and assembled into figures using
Photoshop CS2 (Adobe).
Immunoprecipitation and Blotting
For coprecipitation of endogenous HsCYK-4-associated pro-
teins (Figure 2C), HeLa cells were split into T-75 flasks at 20%
density in the presence of thymidine. After 24 h, cells were washed
twice with Hank’s balanced salt solution (HBSS) and released into
fresh medium. After an additional 12 h, thymidine was added.
Fifteen hours later, cells were washed twice with HBSS and
released into fresh medium containing nocodazole. After 12 h,
cells were washed twice and transferred into nocodazole-free
medium. At each timepoint, DSP was added for 10 min to
stabilize HsCYK-4 associated proteins, followed by quenching in
0.1 M Tris pH 8.0 for 10 min. Cells were collected and lysed in
buffer (50 mM HEPES pH 7.5, 100 mM NaCl, 0.5% NP-40,
10% glycerol) containing phosphatase inhibitors (10 mM sodium
pyrophosphate, 5 mM b-glycerolphosphate, 50 mM NaF,
0.3 mM Na3VO4), protease inhibitors (1mM PMSF, 16protease
inhibitor cocktail (Sigma)), and 1 mM dithiothreitol. Two
micrograms anti-HsCYK-4 antibody or control goat IgG was
added to 1 mg extract on ice, followed by retrieval of immune
complexes with a 1:1 mixture of protein A- and protein G-coupled
Sepharose beads. After extensive washes, bead-bound proteins
were boiled in 16Laemmli buffer containing b-mercaptoethanol
to reverse DSP-generated crosslinks prior to SDS-PAGE and
immunoblotting. A similar protocol was used for all other
immunoprecipitation experiments, except that DSP treatment
was omitted. To specifically inhibit the 9E10 anti-myc antibody, a
100-fold excess of competitor peptide (EQKLISEEDL; Anaspec)
was added on ice for 1 h before immunoprecipitation. Far-
Western blotting with the GST-PBD fusion protein was performed
as described [44].
Antibodies
Phosphoepitope-specific antibodies to HsCYK-4 were generat-
ed in rabbits through immunization of pS157- or p170-specific
phosphopeptides (Active Motif). Sera were screened for phosphos-
electivity by peptide dot-blotting and immunofluorescence mi-
croscopy. For affinity purification, phosphopeptides were coupled
to a solid-phase support via maleimide chemistry. Anti-pS170
(rabbit 8044) was used for immunofluorescence (1:500) and
Western blotting (1:1000). Anti-pS157 (rabbit 8041) was used for
immunofluorescence (1:100). Other antibodies used in this study:
Chitin-binding domain (CBD; New England Biolabs) 1:1000 WB;
Citron kinase (Becton Dickinson) 1:200 IF; Ect2 [14] 1:350 IF;
Ect2 sc-1005 (Santa Cruz) 1:1,000 WB; FLAG M2 (Sigma) 1:500
IF, 1:2,000 WB; GST-HRP sc-459 (Santa Cruz), 1:5,000;
RACGAP1 (Abnova) 1:1,000 WB; RACGAP1 (GeneTex) 1:500
IF, IP; GFP clone 3E6 (Invitrogen) 1:1,000 IF; dsRed (detects
mCherry; Clontech) 1:1,000 WB, 1:1,000 IF; Myc 9E10 (MSKCC
Hybridoma Core Facility) IP; myc 9E10-HRP conjugate (Roche)
1:5,000 WB; RhoA sc-418 (Santa Cruz) 1:200 IF; Pds1 DCS-280
(Neomarkers) 1:500 WB; Plk1 N-terminal 06-813 (Millipore) 1:500
WB; Plk1 F-8 (Santa Cruz) 1:1,000 WB; a-tubulin sc-5286 (Santa
Cruz), 1:2,000 WB.
Supporting Information
Figure S1 Expression of Plk1 alleles. Whole-cell extracts
from cells of the indicated genotypes were resolved by SDS-PAGE
and immunoblotted with antibodies specific for Plk1 (top panel) or
mCherry (bottom panel). Note that mCherry- and EGFP-fused
Plk1 proteins differ by only four amino acids in length and thus
comigrate. Asterisk indicates a minor breakdown product of
mCherry-Plk1 fusion proteins. A nonspecific band used as a
loading control is also indicated.
Found at: doi:10.1371/journal.pbio.1000111.s001 (0.19 MB PDF)
Figure S2 Identification of HsCYK-4 phosphorylation
sites by mass spectrometry. A recombinant HsCYK-4N
fragment was phosphorylated with purified Plk1 and then
processed for tandem mass spectrometry as detailed in the
Methods. MS/MS spectra of peptides containing the indicated
sites are shown with b-ions in blue and y-ions in red. Ions
indicating neutral loss of phosphate from the precursor are shown
in green.
Found at: doi:10.1371/journal.pbio.1000111.s002 (0.97 MB PDF)
Figure S3 Analysis of pS170 in synchronized HeLa cells.
HeLa cells were synchronized by sequential thymidine and
nocodazole blocks and released into drug-free medium at time
0. After sampling at various timepoints, whole-cell extracts were
prepared and immunoprecipitated with anti-HsCYK-4 antibodies,
then immunoblotted to detect either S170 phosphorylation or total
HsCYK-4.
Found at: doi:10.1371/journal.pbio.1000111.s003 (0.14 MB PDF)
Figure S4 Localization of GFP-HsCYK-4 fusions and




were stained with a GFP-specific monoclonal antibody and
analyzed by fluorescence microscopy. Note comparable incorpo-
ration of both GFP-tagged HsCYK-4 alleles into the spindle
midzone. Scale bar, 10 mm. (B) HeLa cells were transiently
transfected with constructs expressing wild-type, S157A, or S170A
versions of FLAG-HsCYK-4 and arrested in mitosis with
nocodazole. Extracts were immunoprecipitated with anti-FLAG
antibody-Sepharose beads, resolved by SDS-PAGE, and immuno-
blotted with anti-pS170 antibody (top) or anti-FLAG antibody
(bottom). Asterisk denotes crossreaction with immunoglobulin
heavy chain. (C) RPE cells were transfected with HsCYK-4 or
mock siRNAs, either before (top two rows) or after (bottom two
rows) stable transduction with retroviruses expressing siRNA-
resistant GFP-HsCYK-4 or GFP-HsCYK-4
S170A. Cells were
stained with goat antibodies to HsCYK-4 (green) and rabbit
anti-pS170 antibodies (red). Note that the S170A transgene
restores HsCYK-4 but not pS170. Scale bar, 10 mm.
Found at: doi:10.1371/journal.pbio.1000111.s004 (0.79 MB PDF)
Figure S5 Validation of the pS157 antibody. (A) Decreas-
ing amounts of phosphorylated (pS157) or unphosphorylated
(S157) peptides were spotted on PVDF membranes and probed
with anti-pS157 antibodies. (B) HeLa cells were transiently
transfected with plasmids expressing wild-type or S157A versions
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and arrested in mitosis with nocodazole. Extracts were immuno-
precipitated with anti-FLAG antibody-Sepharose beads, resolved
by SDS-PAGE, and immunoblotted with anti-pS157 antibody
(top) or anti-FLAG antibody (bottom). Asterisk denotes cross-
reaction with immunoglobulin heavy chain. (C) RPE cells were
transfected with HsCYK-4 or mock siRNAs, either before (top two
rows) or after (bottom two rows) stable transduction with
retroviruses expressing siRNA-resistant GFP-HsCYK-4 or GFP-
HsCYK-4
S157A. Cells were stained with goat antibodies to
HsCYK-4 (green) and rabbit anti-pS157 antibodies (red). Note
that the S157A transgene restores HsCYK-4 but not pS157. Scale
bar, 10 mm.
Found at: doi:10.1371/journal.pbio.1000111.s005 (0.78 MB PDF)
Figure S6 Phosphorylation of serine 157 by Plk1
promotes assembly of the Ect2/HsCYK-4 complex. HeLa
cells were transiently transfected with plasmids expressing FLAG
epitope-tagged HsCYK-4 (wild-type, S157A, and S170A) and myc
epitope-tagged Ect2 (myc-Ect2). Twenty-four hours after trans-
fection, cells were arrested in mitosis for 15 hours with 5 mMS -
trityl-L-cysteine [70] (+ 200 nM BI 2536 where indicated), then
treated with the Cdk1-specific inhibitor RO-3306 [71] for 20 min
to induce mitotic exit. Whole-cell extracts were immunoprecipi-
tated with anti-myc antibodies, resolved by SDS-PAGE, and
immunoblotted with anti-FLAG and anti-myc antibodies.
Found at: doi:10.1371/journal.pbio.1000111.s006 (0.34 MB PDF)




as/catC4 cells. Cells of each genotype were
released from a monastrol block and imaged by phase-contrast
videomicroscopy in the presence of 10 mM 3-MB-PP1. The time
at which each cell entered anaphase was noted and set as time 0,
and the depth of the cleavage furrow was measured at each
subsequent frame (1/min) until the cell exited mitosis and adopted
a flat morphology. Furrow trajectories are displayed as heat maps
to facilitate visual inspection of the dataset.
Found at: doi:10.1371/journal.pbio.1000111.s007 (0.89 MB PDF)
Video S1 Furrow formation is defective in Plk1
as/cat
cells. This movie corresponds to the upper panel in Figure 7A.
Found at: doi:10.1371/journal.pbio.1000111.s008 (3.26 MB
MOV)
Video S2 Furrow formation is rescued in Plk1
as/catC4
cells. This movie corresponds to the lower panel in Figure 7A.
Found at: doi:10.1371/journal.pbio.1000111.s009 (7.11 MB
MOV)
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